![An image showing a [2]catenane](https://d2cbg94ubxgsnp.cloudfront.net/Pictures/274x183/0/0/4/504004_fja0c01757_0007.jpeg_49119.jpg)
Sanjay Kumar
Sanjay Kumar is a science journalist based out of New Delhi and Mumbai, India.
He has reported extensively on science, technology, health and environment for over two decades from the Indian subcontinent for leading international publications. He also serves on the Boards of 'Center for Advancement of Public Understanding of Science & Technology' and 'Science Media Centre-India'.
BusinessCoronavirus pandemic will disrupt international supply chains
Halted production and transport restrictions are straining industries that rely heavily on China for supplies
- News
Financial woes have India’s scientists worried despite budget funding pledges
Fears voiced that the promised investment in research will not materialise once more
- Business
Former Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
- News
India becomes world's largest emitter of sulfur dioxide
Greenpeace study reveals global sulfur dioxide hotspots
- News
Another five years of Modi government leaves Indian scientists worried
Concerns raised that India is falling behind competitors like China and that the government’s commitment to science is weak
- Business
India moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
- Business
India creates national drugs database to address supply and quality issues
Regulatory body takes steps to reform how it manages and monitors pharmaceuticals
- Business
Indian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
- News
Budget fails to impress Indian scientists
Figures show that funding for science has actually fallen as the nation’s economy has grown rapidly
- Business
India’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
- Business
India hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
- Business
Daiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
- Business
Indian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
- Business
Sun Pharma snares Ranbaxy in $4bn deal
Acquisition makes Sun biggest drug firm in India and fifth largest generics producer in the world
- News
Scientists left unimpressed by Indian budget
7.5% funding boost for science and technology fails to offset cuts of more than 20% last year
- Feature
India’s chemistry challenges
India’s climate, its vast population and extremely rapid development make it host to a unique set of challenges. Sanjay Kumar finds out how Indian chemists are developing home-grown solutions
